Two Sigma Securities’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$292K Sell
1,490
-912
-38% -$177K 0.03% 792
2025
Q4
$417K Sell
2,402
-3,951
-62% -$719K 0.06% 472
2025
Q3
$1.21M Buy
+6,353
New +$1.13M 0.18% 126
2023
Q4
Sell
-9,228
Closed -$1.21M 3134
2023
Q3
$1.12M Buy
9,228
+7,543
+448% +$1.01M 0.01% 965
2023
Q2
$237K Sell
1,685
-3,496
-67% -$482K ﹤0.01% 2060
2023
Q1
$733K Buy
+5,181
New +$741K 0.01% 1013
2022
Q3
Sell
-2,326
Closed -$306K 2698
2022
Q2
$309K Buy
+2,326
New +$317K 0.01% 1277
2021
Q3
Sell
-1,524
Closed -$201K 1630
2021
Q2
$201K Buy
+1,524
New +$200K 0.01% 1285
2021
Q1
Sell
-2,301
Closed -$274K 1045
2020
Q4
$274K Buy
+2,301
New +$281K 0.01% 1118
2020
Q3
Sell
-1,938
Closed -$229K 1364
2020
Q2
$221K Buy
+1,938
New +$206K 0.01% 1079
2019
Q3
Sell
-2,497
Closed -$256K 2120
2019
Q2
$254K Sell
2,497
-2,636
-51% -$253K ﹤0.01% 1554
2019
Q1
$462K Buy
+5,133
New +$445K ﹤0.01% 922
2018
Q4
Sell
-3,845
Closed -$360K 2279
2018
Q3
$415K Sell
3,845
-4,277
-53% -$469K ﹤0.01% 1546
2018
Q2
$893K Sell
8,122
-1,113
-12% -$116K ﹤0.01% 1415
2018
Q1
$926K Buy
9,235
+6,811
+281% +$698K 0.01% 1307
2017
Q4
$239K Buy
+2,424
New +$230K 0.01% 1171
2017
Q2
Sell
-2,330
Closed -$229K 918
2017
Q1
$229K Buy
+2,330
New +$222K 0.04% 541

Other funds holding DGX

Two Sigma Securities's DGX Position: Q1 2026 in Review

Two Sigma Securities reduced its Quest Diagnostics (DGX) stake by 38% in Q1 2026, selling an estimated $177K and leaving 1,490 shares worth $292K. The position accounts for 0.03% of the portfolio, ranked #792.

Two Sigma Securities first reported a position in DGX in Q1 2017 and has held it in 17 quarters since. The position peaked at $1.21M in Q3 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Two Sigma Securities held 1,490 shares of Quest Diagnostics worth $292K as of Q1 2026.
  • Two Sigma Securities sold 912 Quest Diagnostics shares in Q1 2026, an estimated $177K.
  • Quest Diagnostics made up 0.03% of Two Sigma Securities's portfolio in Q1 2026, its #792 holding.
  • Two Sigma Securities first reported a position in Quest Diagnostics in Q1 2017 and has held it in 17 quarters since.
  • Two Sigma Securities's Quest Diagnostics position peaked at $1.21M in Q3 2025.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.